President Xi Jinping proposed innovation of medical devices again at the NPC & CPPCC

  • 2021-03-10
It should be necessary to concentrate on tackling key core technologies and accelerate the solution of "bottlenecks" in a number of fields such as drugs, medical devices, medical equipment and vaccines. It should be necessary to intensify the reform of medical insurance, normalize and institutionalize the centralized procurement of drugs in large quantities, improve the medical insurance and relief system for major and serious diseases, deepen the reform of the medical insurance fund supervision system, and maintain the "lifeline support" of the people.
This was proposed by Xi Jinping, General Secretary of the CPC Central Committee, President of the People's Republic of China, and Chairman of the PRC Central Military Commission, when he participated in the Joint Working Group Meeting of the Medical and Health Industry for the Fourth Session of the 13th CPPCC on March 6. He stressed that we should give priority to the protection of people's health, adhere to the public welfare of basic medical and health undertakings, focus on major diseases and major problems affecting people's health, accelerate the implementation of Healthy China Action, reinforce the national public health protection network, promote the high-quality development of public hospitals, and provide people with all-round and full-cycle health services.

In recent two years, people's health security has attracted high attention at national level, and innovation and high-quality development in the field of medical devices also gain great importance, and relevant supporting policies have been published.


The Strategic Innovation Alliance of Medical Device Technology has been committed to supporting industrial innovation. Relying on the successful holding of three sessions of China Medical Devices Design & Entrepreneurship Competition, the Alliance has provided opportunities for demonstration and exchange of innovation projects, and built a platform for access to various innovation services and industrial resources.